Eczema Patients Have Lost Faith In Treatment: Survey

"); jQuery("#212 h3").html("

Related News Programmes

"); });

2022-09-13 HKT 20:53

Share this story

facebook

  • Eczema patients have lost faith in treatment: survey

A international survey has found that only 37 percent of eczema patients in the city are working on treatment plans with doctors, while two-thirds have lost hope.

GlobalSkin, an international alliance of dermatology patient organisations, initiated the study covering 330 eczema patients in the SAR, South Korea and Australia in August, with one-third of the respondents in Hong Kong.

Dermatologist Dr Johnny Chan said on Tuesday that the proportion of patients in the city seeking medical advice is “very low”.

He said more than 90 percent of them are being treated by public practitioners, but strained medical resources due to the Covid-19 pandemic have delayed their treatment.

“The queue time of every [eczema] treatment will be two to three years at the moment," he said, adding that does not taken into account the impact Covid has had on waiting times even longer.

“While they are waiting, they think the treatments will not be helping them, and may lose the faith in treatment. They think it’s just incurable, they don’t want to have any treatment anymore,” Chan said.

“Public doctors have a limited time to see a lot of patients every day."

But for moderate to severe cases, he said, "they need some more time for explanations about the disease nature: to have a more tailor-made treatment plan for the patients, and to explain any possible side effects and the way to avoid these side effects.”

Chan added that less than 10 percent of eczema sufferers had sought treatment from the private sector. He said high costs was "very much an issue" here, with 72 percent of patients saying the heavy financial burden had deterred them from visiting doctors.

Dr Marco Ho, who chairs the Hong Kong Allergy Association, said when treatment is delayed, a patients’ immune system further deregulates and their conditions worsen, hence their expectations in consultations can be over-optimistic.

“Sometimes you don’t have the best-matched medication treatment as well as therapies. They have a whole lot of ideas and their own personal belief, so end up when we say ‘control’, they say ‘cure’; when we say ‘short-term gain’, they want a ‘long-term' remission,” he said.

“At times we even think the patient needs hospitalisation [but] they can't afford to stop their work or school.”

To clear up such misinterpretations and handle mental problems when patients are suffering from skin conditions, the allergy association and a concern group under the Hong Kong Health Care Alliance launched a free online counseling service on Tuesday that will run for three months.

RECENT NEWS

Eric Trump To Speak At Bitcoin Asia 2025 In Hong Kong

Eric Trump, the second son of US president Donald Trump, is set to speak at the upcoming Bitcoin Asia 2025 conference i... Read more

Hong Kong Digital Banking Survey Reveals User Concerns And Growth Potential

ECHO ASIA, partnering with students from Global Business Studies, CUHK Business School, announced the release of the H... Read more

InvestHK Attracts HK$160 Billion In 2025, With Fintech As Top Sector

Invest Hong Kong (InvestHK) announced on 7 July 2025 that it supported over 1,300 overseas and Mainland companies in se... Read more

ZhongAn Online Completes US$500M H Share Placement To Fuel Core Insurance Growth

ZhongAn Online P & C Insurance Co., Ltd (Zhong An, HKEX:6060) announced the completion of its H share placement on ... Read more

Beyond KYC: How Technology Is Transforming The Fraud Prevention Game

Digital wallets and cryptocurrencies are two of the most targeted channels for fraud this year, according to SEON’s 2... Read more

2025 Hong Kong Fintech Report: What You Need To Know

Hong Kong is hitting the gas when it comes to fintech innovation, regulation and adoption. From the passage of the Stab... Read more